ÐÓ°ÉÔ­´´

SafeHeal, based in Paris, shows significant business potential with its innovative solution for protecting digestive anastomosis. By reducing post-surgical complications, SafeHeal addresses a major issue in current surgical practices, which typically involve higher risks and extensive post-operative monitoring. Focusing on anastomosis can improve patient outcomes, shorten recovery times, and lower healthcare costs. Supported by investors like Sofinnova Partners and operating on a solid B2B model, SafeHeal is poised to become a valuable player in the health tech and medical manufacturing sectors.